Cannabidiol for the treatment of autism spectrum disorder: hope or hype?

Key Findings:  This review of the current data (preclinical and clinical) supports that endocannabinoids pay a role in Autism spectrum disorder (ASD), and that cannabidiol (CBD) may provide therapeutic uses in the treatment of symptoms and comorbidities associated with ASD.

Type of Study:  Meta-analysis

Study Result:  Positive

Study Location(s):  Brazil

Year of Pub:  2022

Cannabinoids Studied:  Cannabidiol (CBD), Endocannabinoid (unspecified)

Phytocannabinoid Source:  Unspecified

Chemotype:  Chemotype III